Abstract 277: Comparison of All-Cause Hospitalization Rates and 30-Day Readmissions Among Patients With Non-Valvular Atrial Fibrillation, Newly Diagnosed and Newly Treated With Dabigatran, Rivaroxaban or Warfarin [Session Title: Poster Session PM]

Conclusions: Adjusted results show dabigatran patients had significantly lower all-cause hospitalization compared to rivaroxaban and warfarin patients. Fewer dabigatran patients experienced a 30-day readmission post-discharge compared to warfarin patients and similar 30-day readmission post-discharge compared to rivaroxaban patients.

Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Gilligan, A., Franchino-Elder, J., Song, X., Wang, C., Henriques, C., Sainski-Nguyen, A., Wilson, K., Smith, D., Sander, S. Tags: Session Title: Poster Session PM Source Type: research